Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Active, not recruiting · NCT04821141 · Registry updated 2025-10-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens | Hot Flashes, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2025-10-29 | NCT04821141 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Kansas Medical Center | 169 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Medical Center | Duarte | United States | 313 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Northwestern Medical Center | Chicago | United States | 1 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| University of California San Francisco | San Francisco | United States | 27 |
| University of Kansas Medical Center | Kansas City | United States | 240 |